JAK Inhibitors for the Treatment of Alopecia Areata

    May 2019
    Lijuan Yu
    Studysummary This study suggests that oral JAK inhibitors can be an effective treatment option for approximately half of patients with moderate to severe alopecia areata, despite variable responses and potential adverse effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on rs.yiigle.com →
    Discuss this study in the Community →

    Related research 13

    1. Tofacitinib Treatment in Patients With Active COVID-19 Infection Curēus · 2021
    2. Rapidly Progressive Alopecia Areata Totalis in a COVID-19 Patient, Unresponsive to Tofacitinib Journal of the European Academy of Dermatology and Venereology · 2021
    3. Experience with Oral Tofacitinib in Severe Alopecia Areata with Different Clinical Responses Journal of Cosmetic Dermatology · 2021
    4. Efficacy of JAK 1/2 Inhibition in the Treatment of Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Annals of the rheumatic diseases · 2020
    5. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata Dermatology and therapy · 2019
    6. 2-Deoxy D-Glucose Treatment Does Not Elicit a Hair Growth Response in Alopecia Areata Experimental Dermatology · 2019
    7. Alopecia Universalis Under Adalimumab Therapy in a Patient with Rheumatoid Arthritis Zeitschrift für Rheumatologie · 2018
    8. Topical Janus Kinase Inhibitors: A Review of Applications in Dermatology Journal of the American Academy of Dermatology · 2018
    9. Treatment of an Alopecia Areata Patient with Tofacitinib Results in Regrowth of Hair and Changes in Serum and Skin Biomarkers Experimental Dermatology · 2016
    10. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib EBioMedicine · 2015
    11. Alopecia Universalis Successfully Treated With Adalimumab JAMA dermatology · 2014
    12. Alopecia Areata as Another Immune-Mediated Disease Developed in Patients Treated with Tumor Necrosis Factor-Alpha Blocker Agents Journal of the European Academy of Dermatology and Venereology · 2010
    13. Alopecia Areata Universalis After Phenobarbital-Induced Anticonvulsant Hypersensitivity Syndrome Immunological investigations · 2009